Slide 1TREATING LIPIDS FOR PREVENTION OF CAD : HOW AGGRESSIVE SHOULD WE BE? Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full…

1. Lipid lowering therapy in CKDWhat is the evidence? Conall O’ Seaghdha Renal Meeting Royal North Shore Hospital 29/08/07 2. Case for Discussion 72 male type II DM ESKD…

Slide 1 The efFects of Pharmacological management of lipids in patients with CKD Andrew Monson FY1 18/9/14 Slide 2 The SHARP (Study of Heart and Renal Protection) trial Background…

Slide 1 The Importance of Potential Statin in High Risk Patient Masrul Syafri Bagian Kardiologi & Kedokteran Vaskular FKUA/RS M Djamil Padang CRE/006/FEB14-FEB15/BR Slide…

Slide 1 LIPID LOWERING IN T2D (The Lower the Better?) CONS… TARGETING HARD CVD END POINTS Charles SAAB MD Consultant Endocrinologist DCRP Sacre-Coeur University Hospital-Lebanon…

Slide 1 Should we?? Slide 2 Aspirin is useful! It is widely used in secondary prevention It reduces the yearly risk of vascular events by about a quarter This corresponds…

Slide 1 How To Be Healthy Without Killing Yourself B Bottenberg, D.O., FNLA, FACOI Slide 2 Topics For Today Major Risk Factors For Disease Disease Prevention Diet and Exercise…

Slide 1 Disclosures / Conflicts of Interest Alfred K. Cheung, M.D. None relevant to this topic Slide 2 Slide 3 Lipid Control Is it really needed in the ESRD patient? ESRD:…

Aggressive Lipid Lowering Treatment Richard CESKA Centre of Preventive Cardiology University Hospital, Prague, Czech Republic International Atherosclerosis Society Chair:…

Case Study “SK” ApoE-OM3FA Interaction KIF6 LDL Subclasses Downloaded from www.atheroregression.com Dmitri Vasin MD Drew Garcia PA-C Atherosclerosis Regression Clinic…